Glycinorm Total 30 mg/7.5 mg/500mg Tablet

Gliclazide (30mg) + Pioglitazone (7.5mg) + Metformin (500mg) Primary uses of : Type 2 diabetes
Manufacturer: Ipca Laboratories Ltd
*
₹ 0.00 incl tax
Composition Gliclazide (30mg) + Pioglitazone (7.5mg) + Metformin (500mg)
Potentially Unsafe With Alcohol
Side Effect Common Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Headache, Edema (swelling), Weight gain, Blurred vision, Bone fracture, Respiratory tract infection.
How to works How Glycinorm Total Tablet works Glycinorm Total 30 mg/7.5 mg/500mg Tablet is a combination of three antidiabetic medicines: Gliclazide, Pioglitazone and Metformin. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Gliclazide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Pioglitazone is a thiazolidinedione which increases insulin sensitivity. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and further increasing the body's sensitivity to insulin.